sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
1-May-2016 09:47
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 401-425 out of 1221.

<< < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>

Public Release: 9-Sep-2015
PLOS Neglected Tropical Diseases
Brain plasticity in the most dreaded biblical disease
A new study shows that nerve damage caused by leprosy is associated to changes in the brain of patients.
National Counsel of Technological and Scientific Development, Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro, Brazilian Innovation Agency, and others

Contact: Claudia Vargas
claudiadvargas@gmail.com
55-219-961-31053
Publicase Comunicação Científica

Public Release: 9-Sep-2015
Science Translational Medicine
Study IDs viral protein that causes dengue shock
UC Berkeley scientists have identified a viral protein secreted by cells infected with the dengue virus as a key culprit behind the fluid loss and resulting shock that are the hallmark of severe -- and potentially fatal -- infections.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley

Public Release: 9-Sep-2015
Science Translational Medicine
UQ scientists close in on first dengue treatment
Clinical trials for a dengue fever treatment could start within a year, following a discovery by University of Queensland scientists. UQ's School of Chemistry and Molecular Biosciences Head Professor Paul Young said the researchers had identified similarities in how the body reacted to dengue virus and bacterial infections, in a finding that would allow them to repurpose existing drugs.
National Health and Medical Research Council

Contact: Paul Young
p.young@uq.edu.au
61-733-654-622
University of Queensland

Public Release: 8-Sep-2015
The FASEB Journal
Hypertension in professional football players likely results from trauma on the field
The regular physical trauma that appears to put professional football players at risk for degenerative brain disease may also increase their risk for hypertension and cardiovascular disease, researchers say.
American Heart Association, National Institutes of Health

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Augusta University

Public Release: 8-Sep-2015
Angewandte Chemie International Edition
Pitt researchers developing a novel way to identify pathogens
The University of Pittsburgh's Xinyu Liu, Sanford Asher, and colleagues may have found a faster method to identify pathogens.

Contact: Joe Miksch
jmiksch@pitt.edu
412-624-4356
University of Pittsburgh

Public Release: 8-Sep-2015
Drugs for Neglected Diseases initiative unveils new plan for neglected patients
After having built the world's largest drug development pipeline for the most neglected diseases, the Drugs for Neglected Diseases initiative has unveiled plans for a more flexible, dynamic portfolio approach, integrating various operating models to better respond to the needs of patients, notably in low- and middle-income countries. The plan also paves the way for new diseases to be taken up in DNDi's portfolio.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 8-Sep-2015
European Congress on Tropical Medicine and International Health ECTMIH
Clinical trial for first oral drug candidate specifically developed for sleeping sickness
The Drugs for Neglected Diseases initiative has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 8-Sep-2015
PLOS ONE
Umeå researcher explains the increase in dengue epidemics in Singapore
Population growth and increased temperature are the most important explanations to the significant increase of dengue incidence in Singapore since the 1970s. This is shown in a study undertaken by Joacim Rocklöv and his colleagues at the unit of Epidemiology and Global Health at Umeå University in Sweden, published in the journal PLOS ONE.

Contact: Mattias Grundström Mitz
46-907-866-465
Umea University

Public Release: 8-Sep-2015
Dissertations
Swedish surgical research stops suffering for millions of impoverished citizens
Mosquito mesh cannot just prevent malaria, but can also be used to reduce the suffering caused by groin hernia. A surgical operation using mosquito mesh to repair the hernia can give millions of people a chance at a better life. This according to a study performed in collaboration with Umeå University, Sweden.

Contact: Mattias Grundström Mitz
mattias.mitz@umu.se
46-907-866-465
Umea University

Public Release: 8-Sep-2015
JAMA
Iron supplementation during pregnancy and risk of malaria in malaria-endemic region
Among women in a malaria-endemic region in Kenya, daily iron supplementation during pregnancy did not result in an increased risk of malaria, according to a study in the Sept. 8 issue of JAMA. Iron supplementation did result in increased birth weight, gestational duration, neonatal length, and a decreased risk of low birth weight and prematurity.

Contact: Martin N. Mwangi
mart.mwangi@gmail.com
The JAMA Network Journals

Public Release: 8-Sep-2015
Scientific Reports
Nature: Study creates cell immunity to parasite that infects 50 million
Multi-institution, multidisciplinary study applies cancer science technique to field of infectious diseases to pinpoint human genes that allow parasite E. histolytica to cause cell death.
National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 8-Sep-2015
Health Affairs
Global health studies in September Health Affairs
The September issue of Health Affairs includes articles examining the growing burden of noncommunicable diseases, both in the United States and elsewhere.

Contact: Amy Martin Vogt
amartinvogt@gymr.com
202-745-5052
Health Affairs

Public Release: 7-Sep-2015
16th World Conference on Lung Cancer
IASLC issues new statement on tobacco control and smoking cessation
The International Association for the Study of Lung Cancer today issued a new statement on Tobacco Control and Smoking Cessation at the 16th World Conference on Lung Cancer in Denver. The statement calls for higher taxes on tobacco products, comprehensive advertising and promotion bans of all tobacco products and product regulation including pack warnings.

Contact: Jeff Wolf
Jeff.Wolf@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer

Public Release: 7-Sep-2015
Proceedings of the National Academy of Sciences
Mobile phone records may predict epidemics of mosquito-borne dengue virus
A new study led by Harvard T.H. Chan School of Public Health researchers finds cell phone records can predict the geographical spread and timing of dengue epidemics. Utilizing the largest data set of cell phone records ever analyzed to estimate human mobility, the researchers developed an innovative model to predict epidemics and provide early warning to policy makers.
James S. McDonnell Foundation, Wellcome Trust, Models of Infectious Disease Agent Study

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard T.H. Chan School of Public Health

Public Release: 3-Sep-2015
PLOS ONE
Rapid testing for TB aims to reduce drug resistance, lower mortality rate
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis, which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 1-Sep-2015
Hepatology
Cirrhosis, antibodies increase risk of poor outcome for autoimmune hepatitis patients
New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen/liver pancreas antigen are major risk factors for poor short- and long-term outcome in patients with autoimmune hepatitis.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 1-Sep-2015
UC San Diego scientists investigate global hemorrhagic fever bacterial disease
An international research team, headed by Joseph Vinetz, M.D., professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a five-year, $1.89 million cooperative agreement to carry out transnational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 31-Aug-2015
Journal of Women's Health
Sex-specific biomarkers are needed to learn why heart attacks kill more women than men
Disproportionately more women than men die due to cardiovascular disease and heart attacks in the US, and current risk scoring systems -- based on factors measured mainly in male populations -- are poor predictors of mortality risk for women who suffer cardiac arrest. The need for sex-specific bio-marker and risk stratification tools to improve diagnosis and treatment is clearly described in the Editorial 'Sex, Myocardial Infarction, and the Failure of Risk Scores in Women', published in Journal of Women's Health.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 27-Aug-2015
Journal of General Internal Medicine
Survey finds many physicians overestimate their ability to assess patients' risk of Ebola
While most primary care physicians responding to a survey expressed confidence in their ability to identify potential cases of Ebola and communicate Ebola risks to their patients, when asked how they would care for hypothetical patients who might have been exposed to Ebola, less than 70 percent gave answers fitting CDC guidelines. Those least likely to encounter an Ebola patient were most likely to choose overly intense management of patients actually at low risk.

Contact: Mike Morrison
mdmorrison@partners.org
617-724-6425
Massachusetts General Hospital

Public Release: 27-Aug-2015
PLOS Pathogens
A patient shedding poliovirus for 28 years -- possible challenges for polio eradication
With all but two countries worldwide, Pakistan and Afghanistan, declared polio-free, the eradication of the devastating viral disease in the near future is a real possibility. A study published on Aug. 27 in PLOS Pathogens reports results from an individual in the UK with an immune disease whose stool samples have contained large amounts of live polio virus for over 20 years. Patients like this one, the authors suggest, could start new polio outbreaks and complicate polio eradication as currently planned.

Contact: Javier Martin
javier.martin@nibsc.org
44-170-764-1295
PLOS

Public Release: 26-Aug-2015
The Lancet
Life expectancy climbs globally but more time spent living with illness and disability
People around the world are living longer, even in some of the poorest countries, but a complex mix of fatal and nonfatal ailments causes a tremendous amount of health loss, according to a new analysis of all major diseases and injuries in 188 countries. Global life expectancy at birth for both sexes rose by 6.2 years, while healthy life expectancy, or HALE, at birth rose by 5.4 years.

Contact: Rhonda Stewart
stewartr@uw.edu
Institute for Health Metrics and Evaluation

Public Release: 25-Aug-2015
PLOS Medicine
Less may be more in slowing cholera epidemics
An oral cholera vaccine that is in short supply could treat more people and save more lives in crisis situations, if one dose were dispensed instead of the recommended two, new Johns Hopkins Bloomberg School of Public Health research suggests.
The Bill & Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 25-Aug-2015
BMJ Quality Improvement Reports
Project in West Africa sees dramatic drop in TB death rates
Doctors in Togo, West Africa have seen a 10 percent drop in tuberculosis death rates after redesigning diagnosis and treatment services in one of the country's health districts.

Contact: Gozde Zorlu
gozde.zorlu@gmail.com
44-207-383-6920
BMJ

Public Release: 25-Aug-2015
PLOS Medicine
One dose or 2? Cholera vaccination strategies
A new modeling study appearing this week in PLOS Medicine supports consideration of vaccination campaigns using a single dose of cholera vaccine versus campaigns using the recommended two doses given two weeks apart. Justin Lessler and colleagues focus their modelling analyses on comparing the number of lives that could be saved by adopting a single vaccine dose, which could be more rapidly administered to more people than the internationally licensed two dose protocol.

Contact: Press Office
medicinepress@plos.org
PLOS

Public Release: 24-Aug-2015
2015 International Conference on Emerging Infectious Diseases
Is MERS another SARS: The facts behind Middle East Respiratory Syndrome
Experts show that while Middle East Respiratory Syndrome, a viral respiratory illness, is infecting less people, it has a higher mortality rate and affects a specific target population when compared to Severe Acute Respiratory Syndrome. This research is being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.

Contact: Aleea Khan
akhan@asmusa.org
202-942-9297
American Society for Microbiology

Showing releases 401-425 out of 1221.

<< < 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 > >>